id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-D-0779-0023,FDA,FDA-2014-D-0779,"Current Good Manufacturing Practice—Guidance for Human Drug
Compounding Outsourcing Facilities Under Section 503B of the FD&C Act; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2018-12-11T05:00:00Z,2018,12,2018-12-11T05:00:00Z,2019-02-12T04:59:59Z,2019-08-20T19:41:28Z,2018-26724,0,0,0900006483980a94
FDA-2014-D-0779-0024,FDA,FDA-2014-D-0779,Draft Guidance for Industry Current Good Manufacturing Practice--Guidance for Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act,Other,,2018-12-11T00:00:00Z,2018,12,,,2024-11-12T22:53:25Z,,0,1,0900006483981ded